Journal

Category

LA&HA - Journal of the Laser and Health Academy

LA&HA - Journal of the Laser and Health Academy

J LA&HA 2012/1

Volume: 2012 | Number: 1
ISSN (print): 1855-9913 | ISSN (web): 1855-9921

Minimally Invasive Laser Procedure for Early Stages of Stress Urinary Incontinence (SUI)

Fistonic Ivan, Findri-Gustek Stefica, Fistonic Nikola
Pages: 67-74

The objective of this labeled, prospective, single-center pilot study study was to assess the efficacy and safety of a novel minimally invasive, non-ablative laser treatment in the early stages of SUI.

 A total of 39 patients suffering from mild-to-moderate stress urinary incontinence underwent treatment with an Er:YAG (2940 nm) laser in non-ablative fractional mode. Assessment tools included the ICIQ-UI SF questionnaire for assessing the degree of incontinence and its impact on the quality of life, the Q-tip test for evaluating the mobility of the urethra and bladder neck, PISQ-12 for assessing quality of life in the area of sexuality, and perineometry for the measurement of muscle strength. Follow-ups were scheduled after 1 month for 39 patients, after 3 months for 22 patients and after 6 months for 6 patients.

Preliminary results of post-treatment evaluation showed significant improvement (p< 0.05) in all the domains tested: ICIQ-UI scores decreased by more than 3 points at all follow-ups. A mean duration of muscle contraction measured with perineometry at 1 month increased by 4.7 s, at 3 months by 11.8 s and at 6 months by 22.8 s. Q-tip angle decreased by 14.7˚ at 1 month follow-up, by 15.9˚ at 3 months and by 22.5˚ at 6 months. PISQ-12 scores increased after 1 month by 5.4 points, after 3 months by 5.9 points and after 6 months by 6.6 points. 

The preliminary results confirm that a minimally invasive, non-ablative fractional laser treatment (IncontiLase™) is an effective, safe and comfortable treatment option for symptom relief in patients with mild and moderate SUI. 

Journal of the Laser and Health Academy

Minimally Invasive Laser Procedure for Early Stages of Stress Urinary Incontinence (SUI)

Fistonic Ivan, Findri-Gustek Stefica, Fistonic Nikola
Pages: 67-74

The objective of this labeled, prospective, single-center pilot study study was to assess the efficacy and safety of a novel minimally invasive, non-ablative laser treatment in the early stages of SUI.

 A total of 39 patients suffering from mild-to-moderate stress urinary incontinence underwent treatment with an Er:YAG (2940 nm) laser in non-ablative fractional mode. Assessment tools included the ICIQ-UI SF questionnaire for assessing the degree of incontinence and its impact on the quality of life, the Q-tip test for evaluating the mobility of the urethra and bladder neck, PISQ-12 for assessing quality of life in the area of sexuality, and perineometry for the measurement of muscle strength. Follow-ups were scheduled after 1 month for 39 patients, after 3 months for 22 patients and after 6 months for 6 patients.

Preliminary results of post-treatment evaluation showed significant improvement (p< 0.05) in all the domains tested: ICIQ-UI scores decreased by more than 3 points at all follow-ups. A mean duration of muscle contraction measured with perineometry at 1 month increased by 4.7 s, at 3 months by 11.8 s and at 6 months by 22.8 s. Q-tip angle decreased by 14.7˚ at 1 month follow-up, by 15.9˚ at 3 months and by 22.5˚ at 6 months. PISQ-12 scores increased after 1 month by 5.4 points, after 3 months by 5.9 points and after 6 months by 6.6 points. 

The preliminary results confirm that a minimally invasive, non-ablative fractional laser treatment (IncontiLase™) is an effective, safe and comfortable treatment option for symptom relief in patients with mild and moderate SUI. 

LA&HA Projects